Atlas Trials

Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke

Clinical trial NCT05691244 · RECRUITING

Trial details

NCT number
NCT05691244
Sponsor
Pharmazz, Inc.
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Acute Ischemic StrokeCerebral Stroke
Start date
2025-07-24
Primary completion
2026-09-01
Enrollment
514

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.